Center Laboratories, Inc.

NT$28.20As of Sun 8 Nov 2026, 12:00 UTC
TPEx:4123Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 1.67%
Div yield 5.90%
ROE 6.00%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.27
PE TTM 22.18
TSR TTM (8.11%)
Mkt cap NT$22.31B
ROIC 0.15%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$34
20.65%
1.96%
Hold 3|11|7|0|4
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.28
0.30
0.32
0.32
14.76%
23.55%
21.32%
14.27%
RevenueNT$B
1.326
1.361
1.372
1.332
6.79%
5.69%
8.86%
3.51%
Peers (US$673.7M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.989
0.182
0.151
EBIT/Intx
1.262
0.167
0.134
Own earn%
(29.95)
(34.15)
(52.95)
Sh yield%
40.19
40.24
40.56
Owners
Insiders/Inst%
3.60
21.10
Short interest%
3.34
SBC / revenue%
2.00
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
18–27
$1 testx
0.2
Incr. ROIC%
10